Suppr超能文献

早期乳腺癌腋窝治疗:过去、现在与未来

Treatment of the axilla in early breast cancer: past, present and future.

作者信息

Chua B, Ung O, Boyages J

机构信息

Department of Radiation Oncology, Westmead Hospital, New South Wales, Australia.

出版信息

ANZ J Surg. 2001 Dec;71(12):729-36. doi: 10.1046/j.1445-1433.2001.02271.x.

Abstract

BACKGROUND

The optimal treatment of the axilla in early breast cancer is controversial. The present study reviews the pattern and predictors of regional recurrence (RR) and prognosis after RR in patients with early breast cancer treated by conservative surgery and radiotherapy (CS + RT). Implications of the results on current practice and future directions are explored.

METHODS

Between 1979 and 1994, 1158 patients with stage I or II breast cancer were treated with CS + RT at Westmead Hospital. Two groups of patients were compared: 782 patients who underwent axillary dissection (axillary surgery group) and 229 patients who received radiotherapy (axillary RT group) as the only axillary treatment. At least 10 lymph nodes were dissected in 82% of the axillary surgery group. Of the women in the RT group, 90% received RT to the axilla and supraclavicular fossa (SCF) only and 10% also received RT to the internal mammary chain (IMC).

RESULTS

With a median follow-up period of 79 months for the axillary surgery group and 111 months for the axillary RT group, 27 patients developed a RR (2.8% and 2.2%, respectively). Seven patients (0.9%) in the axillary surgery group and three patients (1.3%) in the axillary RT group developed a RR in the axilla (P, not significant). Of the patients with SCF recurrences, 14 (1.8%) were in the axillary surgery group and one (0.4%) in the axillary RT group (P, not significant). One patient in the axillary surgery group developed concurrent axillary and SCF recurrences, while a patient in the axillary RT group developed an IMC recurrence. Twenty (74%) of the 27 patients with a RR developed a concurrent or subsequent distant relapse (30% and 44%, respectively). In the pathologically node-positive patients, the axillary recurrence rate was higher in those who had less than five nodes removed (17%) than those who had 10 or more nodes removed (0%; P = 0.01). The SCF recurrence rate was higher in patients with four or more positive axillary nodes (9.5%) than in those with 0-3 positive nodes (1.5%; P = 0.003).

CONCLUSION

Adequate treatment of the axilla by surgery or RT alone is associated with a low rate of RR. The incidence of distant relapse was substantial in patients who developed a RR, which gives emphasis to the importance of optimizing local-regional control.

摘要

背景

早期乳腺癌腋窝的最佳治疗方法存在争议。本研究回顾了接受保乳手术和放疗(CS + RT)的早期乳腺癌患者区域复发(RR)的模式、预测因素以及RR后的预后情况。探讨了研究结果对当前实践和未来方向的影响。

方法

1979年至1994年间,1158例I期或II期乳腺癌患者在韦斯特米德医院接受了CS + RT治疗。比较了两组患者:782例行腋窝清扫术的患者(腋窝手术组)和229例仅接受放疗作为腋窝唯一治疗的患者(腋窝放疗组)。腋窝手术组82%的患者至少清扫了10个淋巴结。放疗组中,90%的女性仅接受腋窝和锁骨上窝(SCF)放疗,10%的女性还接受了内乳链(IMC)放疗。

结果

腋窝手术组的中位随访期为79个月,腋窝放疗组为111个月,27例患者出现RR(分别为2.8%和2.2%)。腋窝手术组7例患者(0.9%)和腋窝放疗组3例患者(1.3%)出现腋窝RR(P值无统计学意义)。在SCF复发的患者中,腋窝手术组有14例(1.8%),腋窝放疗组有1例(0.4%)(P值无统计学意义)。腋窝手术组1例患者同时出现腋窝和SCF复发,而腋窝放疗组1例患者出现IMC复发。27例出现RR的患者中有20例(74%)同时或随后出现远处复发(分别为30%和44%)。在病理检查淋巴结阳性的患者中,切除淋巴结少于5个的患者腋窝复发率(17%)高于切除10个或更多淋巴结的患者(0%;P = 0.01)。腋窝淋巴结4个或更多阳性的患者SCF复发率(9.5%)高于0 - 3个阳性的患者(1.5%;P = 0.003)。

结论

单纯通过手术或放疗对腋窝进行充分治疗,RR发生率较低。出现RR的患者远处复发率较高,这凸显了优化局部区域控制的重要性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验